Shoulder Innovations, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Robert Joseph Ball
- Full Time Employees
- 75
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1535 Steele Avenue SW Grand Rapids MI United States 49507
- IPO Date
- Jul 31, 2025
- CIK
- 0001699350
- Website
- shoulderinnovations.com
- Similar Companies
- Business
- Shoulder Innovations, Inc. Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company that designs, develops, manufactures, and distributes advanced implant systems for shoulder arthroplasty, including anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA), primarily in the United States. The company offers its proprietary InSet Glenoid technology, which reduces mechanical stress at the bone-implant interface to enhance fixation, stability, and longevity while addressing the rocking horse effect; InSet Total Shoulder System; InSet Reverse Shoulder System with a lateralized-lateralized design for improved range of motion and fewer complications; InSet 70 humeral stem; ProVoyance Shoulder preoperative planning software; and streamlined Dual Tray and Reverse Tray systems optimized for hospital and ambulatory surgery center efficiency. Founded in 2009 by Dr. Steve Gunther and EDF Ventures and headquartered at 1535 Steele Avenue SW, Suite B, Grand Rapids, Michigan, the company targets orthopedic surgeons and patients requiring shoulder replacement solutions amid a growing $2.8 billion global market. Recent developments include the full commercial launch of the InSet 70 humeral stem in September 2025; a $40 million convertible notes financing closed in July 2025 led by Fidelity Management & Research Company to support commercialization and product development; completion of an initial public offering in July 2025 raising $75 million in gross proceeds; expansion of its surgeon customer base by nearly 50% year-over-year; and third-quarter 2025 revenue growth of 58% to $11.8 million, with full-year guidance raised to $42-44 million representing 33-39% growth.
Company News
COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits
Shoulder Innovations to Participate in Upcoming Investor Conferences
BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy
SpaceX (SPCX) Reports Strong Q3 Results and Positive Revenue Guidance
3M and AWS collaborate to advance optical connectivity innovation
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build
Shoulder Innovations Initiates Commercial Launch of the InSet® Go
Shoulder Innovations, Inc. (NYSE:SI) Stock Has Average Target Price of $25.50
Squarepoint Ops LLC Invests $896,000 in Shoulder Innovations, Inc. $SI
Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
Shoulder Innovations Q2 Earnings Call Highlights
Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript
Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook